Wall Street Analysts Believe Sage Therapeutics (SAGE) Could Rally 42.02%: Here's is How to Trade
Portfolio Pulse from
Wall Street analysts have set an average price target for Sage Therapeutics (SAGE) that suggests a potential upside of 42%. This optimism is supported by positive trends in earnings estimate revisions, which could lead to a stock price increase.
January 06, 2025 | 4:30 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Analysts have set a price target for Sage Therapeutics indicating a potential 42% upside, supported by positive earnings estimate revisions.
The article highlights a significant potential upside for SAGE based on analyst price targets and positive earnings estimate revisions. This suggests a bullish sentiment and potential stock price increase.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100